NCT05260411 A Study to Evaluate the Efficacy and Safety of AK102 Q6W in Patients With Hyperlipidemia Status COMPLETED Phase PHASE3
NCT05256472 A Study of AK104 Monotherapy or AK104 Plus Axitinib in Advanced/Metastatic Renal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT05255458 A Study to Evaluate the Long-term Efficacy and Safety of AK102 in Patients With Hyperlipidemia Status COMPLETED Phase PHASE3
NCT05255094 A Study to Evaluate the Efficacy and Safety of AK102 in Patients With Hyperlipidemia Status COMPLETED Phase PHASE3
NCT05247684 AK112 Neoadjuvant/Adjuvant Treatment for Resectable NSCLC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05244642 A Phase III Study to Evaluate the Efficacy and Safety of Penpulimab in the Relapsed and Refractory Classical Hodgkin's Lymphoma Status RECRUITING Phase PHASE3
NCT05235542 A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT05235516 A Study of AK104/Placebo Combined With Chemoradiotherapy For The Treatment of Locally Advanced Cervical Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05229497 A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05227664 A Study of AK117/AK112 in Metastatic Triple-Negative Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05215067 A Phase II Trial of AK104 in Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT05200273 A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK114 Status UNKNOWN Phase PHASE1
NCT05184712 Phase 3 Clinical Study of AK112 for NSCLC Patients Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05155020 A Study to Evaluate the Efficacy and Safety of AK120 in the Treatment of Subjects With Moderate-to-severe Asthma Status TERMINATED Phase PHASE2
NCT05142423 A Study of AK109 Combined With AK104 in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT05120297 A Phase 3 Study of Efficacy and Safety of AK101 in Subjects With Psoriasis Status COMPLETED Phase PHASE3